christopher aiken Archives
Key factors in HIV-1 replication
Feb. 8, 2021—HIV-1, the virus that causes AIDS, exploits inositol phosphates in T cells to aid its own assembly and maturation — suggesting that targeting inositol phosphate binding could inhibit HIV-1 replication.
Restricting HIV-1 infection
Sep. 1, 2017—Vanderbilt researchers are discovering ways that host proteins block HIV-1 infection, which could suggest new avenues for treatment.
Discussing retroviruses
Mar. 16, 2017—The Rockefeller University’s Paul Bieniasz, Ph.D., center, here with Vanderbilt’s Samuel Santoro, Ph.D., left, and Christopher Aiken, Ph.D., discussed his research on retroviruses at his recent Flexner Discovery Lecture, which was sponsored by the Department of Pathology, Microbiology and Immunology.
Nine professors honored at endowed chair holder celebration
Sep. 9, 2015—The extraordinary achievements of nine Vanderbilt endowed chair holders were lauded at a Sept. 8 celebration during which generous donors were thanked.
Targeting HIV’s “cap”
Feb. 10, 2015—New findings underscore the attractiveness of the HIV capsid – the structure that encloses the viral genome – as a therapeutic target.
Vanderbilt celebrates 18 elected fellows of the AAAS
Nov. 25, 2013—Eighteen academic and administrative leaders at Vanderbilt University have been elected fellows of the American Association for the Advancement of Science (AAAS) this year.
2013 Academic Enterprise Faculty Awards
May. 23, 2013—The 2013 Vanderbilt University Medical Center Academic Enterprise Faculty Awards, which were presented during Wednesday’s Spring Faculty meeting, included awards for Excellence in Teaching and Outstanding Contributions to Research. Award recipients were nominated by their faculty colleagues and chosen by the Academic Enterprise Faculty Awards Selection Committee.
